Search results
Author(s):
Vasvi Singh
Added:
2 months ago
Navigate the diagnostic complexities of cardiac amyloidosis through expert multimodality imaging techniques with Dr Vasvi Singh.This comprehensive presentation, part of the Cardiomyopathies track, addresses the critical role of advanced imaging in diagnosing cardiac amyloidosis. Dr Singh explores the nuanced differences between SPECT and SPECT-CT imaging capabilities, providing practical insights…
View more
Author(s):
Daniel Murphy
,
Debasish Banerjee
Added:
2 months ago
Author(s):
Added:
2 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly…
View more
Author(s):
Harriette Van Spall
,
Udo Bavendiek
Added:
2 months ago
ESC Congress 2025 - Digitoxin reduced the risk of all-cause mortality and hospitalisation in patients with worsening heart failure.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Udo Bavendiek to explore the DIGIT-HF trial, investigating whether digitoxin can improve outcomes in patients with advanced chronic heart failure and reduced ejection fraction.This landmark study…
View more
Author(s):
Alexander van Rosendael
,
Dipti Itchhaporia
Added:
1 year ago
In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, Newport Beach, CA, US) is joined by Dr Alexander Van Rosendael (Leiden University Medical Center, Leiden, NL) to discuss the findings from the CONFIRM2 trial. Conducted from up to 50 international clinical CCTA sites with 35,000 patients, CONFIRM2 aims to improve comprehensive…
View more
Author(s):
Brian Lindman
Added:
7 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
Author(s):
Deesha Patel
,
Makrina D Savvidou
Added:
1 year ago
Author(s):
Deborah C Nercolini
Added:
3 months ago
Explore the critical role of comprehensive CT angiography analysis in pre-procedural TAVR planning with Dr Deborah C Nercolini.This presentation, part of the Structural Interventions track, delves into the meticulous anatomical assessment that guides optimal TAVR device selection and implantation strategy. Dr Nercolini addresses the essential measurements and anatomical considerations that…
View more
Michael L Ridner
Job title: Medical Director of Cardiac Catheterization and Cardiac Computed Tomography
Author
João L Cavalcante
Research Area(s) / Expertise:
Job title: Director of Cardiac MRI and Structural CT Labs
Author